Circulating Pregenomic HBV RNA is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue Therapy
Mark Anderson, Jeffery Gersch, Ka-Cheung Luk, George Dawson, Ivana Carey, Kosh Agarwal, Pir Shah, Geoffrey Dusheiko, Daryl Lau, Gavin Cloherty
Clinical Infectious Diseases, ciaa1015, https://doi.org/10.1093/cid/ciaa1015
Published:
20 July 2020
Article history
Cite
Permissions Icon Permissions
Share
Abstract
HBV RNA is detectable in the serum of infected patients, however the RNA species has been questioned. We tested 1827 specimens using a quantitative dual-target qPCR assay and determined full-length pregenomic RNA is the primary source. These results clarify the major identity of circulating HBV RNA species.
Hepatitis B Virus, pregenomic RNA, Viral Diagnostic Assay, Quantitative PCR
Topic: